Karen L. Daniel - Nov 19, 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Nov 19, 2021
Transactions value $
-$12,571
Form type
4
Date filed
11/23/2021, 03:12 PM
Previous filing
Nov 21, 2022
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +436 +1.04% 42.4K Nov 19, 2021 Direct F1
transaction TDOC Common Stock Sale -$12.6K -109 -0.26% $115.33* 42.2K Nov 22, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -436 -33.33% $0.00 872 Nov 19, 2021 Common Stock 436 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2021.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.